ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Saroja Pharma Industries India Limited appointed Mr. Ravindra Shivaji Salaskar as Chief Financial Officer. He currently serves as a Whole-time Director of the company.
Saroja Pharma Industries India Limited has issued a notice for its 8th Annual General Meeting, scheduled to be held on September 30, 2026, through video conferencing.
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Saroja Pharma announced the re-designation of Mr. Pulinattu Damodaran Nandakumar as Whole-time Director and the appointment of Mr. Niraj Variava as Internal Auditor.
Saroja Pharma confirms zero deviation in utilizing ₹9.11 Crore raised via IPO. The funds were fully deployed for manufacturing setup, debt repayment, and issue expenses.
Saroja Pharma Industries India Limited submitted its annual SDD compliance certificate for FY2026. The auditor confirmed full compliance with SEBI insider trading database requirements.
Saroja Pharma Industries India Ltd reported revenue from operations of ₹31.8 Cr (-9.1% YoY) and net profit of ₹1 Cr (+42.9% YoY) for H2 FY26.
Saroja Pharma approved its FY2026 audited financial results, reporting an annual total income of ₹70.24 Crore. The board confirmed an unmodified auditor's opinion on these standalone figures.